CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.59 CNY | -0.12% |
|
+1.06% | -27.57% |
| Sales 2024 * | 6.16B 850M | Sales 2025 * | 7.06B 974M | Capitalization | 8.77B 1.21B |
|---|---|---|---|---|---|
| Net income 2024 * | 493M 68.04M | Net income 2025 * | 652M 89.99M | EV / Sales 2024 * | 1.43 x |
| Net Debt 2024 * | 48.72M 6.72M | Net cash position 2025 * | 128M 17.64M | EV / Sales 2025 * | 1.23 x |
| P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
13.2
x | Employees | 4,326 |
| Yield 2024 * |
2.07% | Yield 2025 * |
2.49% | Free-Float | 48.06% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.12% | ||
| 1 week | +1.06% | ||
| Current month | -8.42% | ||
| 1 month | -10.33% | ||
| 3 months | -13.06% | ||
| 6 months | -17.24% | ||
| Current year | -27.57% |
1 week
8.32
8.65
1 month
8.2210.07
Current year
7.7712.28
1 year
7.7714.60
3 years
7.7716.23
5 years
6.5520.77
10 years
5.1120.77
| Managers | Title | Age | Since |
|---|---|---|---|
Dong Xun Wu
CEO | Chief Executive Officer | 59 | 17-07-20 |
Jin Jian Huang
DFI | Director of Finance/CFO | 61 | 18-08-30 |
Yan Shang
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Cheng Wang
CHM | Chairman | 61 | 16-12-08 |
Xue Lin Li
BRD | Director/Board Member | 59 | 17-09-10 |
Shi Zhong Hou
CHM | Chairman | 59 | 14-01-16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 8.59 | -0.12% | 9,646,505 |
| 24-04-23 | 8.6 | +0.58% | 7,952,426 |
| 24-04-22 | 8.55 | +2.27% | 11,718,740 |
| 24-04-19 | 8.36 | -0.83% | 7,936,533 |
| 24-04-18 | 8.43 | -0.82% | 10,685,240 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
China Animal Husbandry Industry Co., Ltd. is a China-based company, principally engaged in the manufacture and sales of biological products for livestock. The Company conducts its businesses through four segments, including Animal Biological Products segment, Veterinary Chemicals segment, Feed and Feed Additives segment and Trading segment. The Company mainly provides vaccines, including vaccines for fowls, avian influenza vaccines, foot-and-mouth disease vaccines and swine vaccines, among others. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
8.59
CNY
Average target price
11.45
CNY
Spread / Average Target
+33.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.57% | 1.21B | |
| -10.67% | 6.64B | |
| +16.00% | 3.41B | |
| +0.14% | 3.21B | |
| +2.53% | 1.46B | |
| -14.67% | 1.38B | |
| -2.44% | 1.25B | |
| -12.86% | 1.13B | |
| -2.99% | 1.03B | |
| -6.00% | 843M |
- Stock Market
- Equities
- 600195 Stock
